Rationale for the observed COX-2/COX-1 selectivity of celecoxib from Monte Carlo simulations

被引：21
|
作者：
Price, MLP [1 ]
Jorgensen, WL [1 ]
机构：
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2001年 / 11卷 / 12期
关键词：
D O I：
10.1016/S0960-894X(00)00522-9
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Computational studies have yielded an analysis of the contributions to the free energy difference between the binding of celecoxib to COX-1 and to COX-2. The energetic and structural results point to the Ile to Val mutation at residue 523 as the key contributor to COX-2 selectivity; unfavorable steric contact between a sulfonamide oxygen and the delta methyl group of Ile523 destabilizes the complex with COX-1. The His to Arg change at residue 513 is less significant. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1541 / 1544
页数：4
相关论文
共 50 条
  • [21] The molecular basis of COX-2 versus COX-1 selectivity of lumiracoxib by molecular docking studies
    Correa, Celia M.
    de Paula, Andre F.
    da Silva, Gilberto M. S.
    Sant'Anna, Carlos M. R.
    Fraga, Carlos A. M.
    Barreiro, Eliezer J.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (06) : 422 - 425
  • [22] COX-1/COX-2 inhibitors based on the methanone moiety
    Dannhardt, G
    Fiebich, BL
    Schweppenhäuser, J
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (02) : 147 - 161
  • [23] Expression of Cox-1 and Cox-2 in canine mammary tumours
    Queiroga, F. L.
    Alves, A.
    Pires, I.
    Lopes, C.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2007, 136 (2-3) : 177 - 185
  • [24] Development of more selective NSAIDS: Cox-1 and Cox-2
    Barragry, T
    IRISH VETERINARY JOURNAL, 1996, 49 (09) : 553 - &
  • [25] Carcinogen substrate specificity of human COX-1 and COX-2
    Wiese, FW
    Thompson, PA
    Kadlubar, FF
    CARCINOGENESIS, 2001, 22 (01) : 5 - 10
  • [26] Distribution of COX-1 and COX-2 in normal and inflamed tissues
    Seibert, K
    Zhang, Y
    Leahy, K
    Hauser, S
    Masferrer, J
    Isakson, P
    EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION, AND RADIATION INJURY 2, PTS A AND B, 1997, 400 : 167 - 170
  • [27] The role of COX-1 and COX-2 isozymes in experimental cholera
    Gessell-Lee, DL
    Peterson, JW
    GASTROENTEROLOGY, 2001, 120 (05) : A323 - A323
  • [28] Does the COX-1/COX-2 concept still hold?
    Hawkey, C
    UPDATE GASTROENTEROLOGY 2004: NEW DEVELOPMENTS IN THE MANAGEMENT OF BENIGN GASTROINTESTINAL DISORDERS, 2004, : 87 - 89
  • [29] COX-2, but not COX-1, is involved in mechanotransduction in bone cells
    Bakker, AD
    Burger, EH
    Semeins, CM
    Klein-Nulend, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S215 - S215
  • [30] Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): Rationale for selective inhibition and progress to date
    Griswold, DE
    Adams, JL
    MEDICINAL RESEARCH REVIEWS, 1996, 16 (02) : 181 - 206
12345